IDIVAL Joins the European Joint Action JADE Health to Advance Dementia Prevention and Treatment

The Valdecilla Health Research Institute (IDIVAL) is participating as an associate entity in the European project JADE Health (Joint Action on Dementia and Health System Sustainability), a joint action funded by the European Commission under the EU4Health program. This initiative, which brings together institutions from various European countries, aims to improve prevention, early diagnosis, and integrated care for dementia and other neurodegenerative disorders.

JADE Health seeks to develop strategies to address the growing burden of dementia in Europe and enhance the sustainability of healthcare systems. The joint action is designed to strengthen collaboration among member states in the prevention, early detection, diagnosis, and care of dementia and stroke, promoting evidence-based innovative approaches.

The JADE Health project, with full information available on its website (jadementia.eu), recently held its inaugural meeting in Mérida. During this event, project partners established the working framework for the coming years.

At IDIVAL, a team of researchers led by Eloy Rodríguez, including Francisco Martínez, Carmen Lage, María Bravo, Carlos Fernández Viadero, and Miguel Ángel Martínez-Antón, will actively contribute to three of the project’s work packages (6, 7, and 8). Their work will focus on several key areas, including:

Identifying unmet needs, challenges, and benefits in the early detection of Alzheimer’s disease and the use of biomarkers in prevention and treatment strategies.
Producing country-specific reports based on real-world data to guide policymakers and decision-makers in dementia and stroke prevention strategies.
Developing and testing a predictive model for potentially preventable cases of dementia and stroke, based on the prevalence of country-specific risk factors.
Defining and harmonizing the characteristics of a European risk factor surveillance system for dementia and stroke.
Analyzing the current state of post-diagnosis integrated care for people with dementia and neurodegenerative disorders.
Designing and implementing pilot actions to improve integrated care for individuals with a potential dementia diagnosis.
Formulating recommendations to develop services and clinical pathways that ensure sustainable care models, considering resource allocation, accessibility, and equity in care quality.

Through its participation in JADE Health, IDIVAL strengthens its commitment to public health research and innovation in the care of patients with neurodegenerative diseases. This work will contribute to generating evidence to improve dementia prevention and treatment strategies at the European level.